From: A novel multiplex-protein array for serum diagnostics of colon cancer: a case–control study
Colon cancer patients (n = 164) | Control patients (n = 119) | Adenoma patients (n = 34) | ||
---|---|---|---|---|
CEA ‡ (ng/mL) | median | 1.26 | 0.51 | 0.82 |
inter-quartile range | 0.54 – 4.01 | 0.36 -1.09 | 0.41 – 1.34 | |
range | 0.08 - 444.32 | 0.14 - 6.05 | 0.12 - 3.62 | |
p-value | < 0.0001 | |||
IL-8 ‡ (pg/mL) | median | 27.46 | 20.47 | 19.97 |
inter-quartile range | 20.20 – 42.36 | 16.78 – 26.21 | 16.20 – 26.52 | |
range | 0.00 - 572.58 | 0.00 - 221.15 | 0.00 - 158.39 | |
p-value | < 0.0001 | |||
VEGF ‡ (pg/mL) | median | 77.99 | 59.94 | 67.86 |
inter-quartile range | 46.78 – 120.94 | 34.99 – 98.70 | 42.95 – 91.41 | |
range | 5.02 - 350.38 | 7.54 - 427.56 | 10.68 - 178.72 | |
p-value | 0.02 | |||
M-CSF ‡ (pg/mL) | median | 8.27 | 7.18 | 6.65 |
inter-quartile range | 6.70 – 12.76 | 5.31 – 10.26 | 5.47 – 8.58 | |
range | 2.26 - 58.23 | 2.99 - 72.86 | 3.50 - 30.55 | |
p-value | 0.02 | |||
S100A11 ‡ (ng/mL) | median | 12.14 | 10.89 | 11.93 |
inter-quartile range | 9. 39 – 15.46 | 7.97 – 14.18 | 9.61 – 16.05 | |
range | 4.37 - 177.68 | 3.99 - 105.25 | 6.69 - 56.93 | |
p-value | 0.04 | |||
NNMT (ng/mL) | median | 1.48 | 1.46 | 1.63 |
inter-quartile range | 0.72 – 4.23 | 0.67 – 4.60 | 0.64 – 7.82 | |
range | 0.25 - 70.00* | 0.27 - 70.00* | 0.28 - 70.00* | |
p-value | > 0.05 | |||
C3a desArg ‡ (ng/mL) | median | 708 | 808 | 660 |
inter-quartile range | 514 – 906 | 538 – 1134 | 344 – 1216 | |
range | 140 - 6114 | 150 - 3316 | 200 - 3282 | |
p-value | 0.04 | |||
CD26 ‡ (ng/mL) | median | 442 | 550 | 614 |
inter-quartile range | 378 – 582 | 428 – 698 | 494 – 750 | |
range | 184 - 1352 | 0.00 - 1034 | 82 – 3980* | |
p-value | 0.0002 | |||
CRP ‡ (ng/mL) | median | 4018 | 2086 | 2020 |
inter-quartile range | 1718 – 9238 | 1188 – 5260 | 1208 – 4768 | |
range | 778 - 59800* | 726 - 59800* | 902 - 59800* | |
p-value | 0.006 |